Deanna Cheung, MD
Hospitalist · Long Beach, CANPI 1336226398
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,287 of the $1,561 with a category attached, or 82.4%. Every reported general payment came from a single manufacturer, Astrazeneca UK Limited. Among hospitalist clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $141.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$2K
Across 251 payments — averaging $2911.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$194K
- Novartis$131K
- Akcea Therapeutics, Inc.$102K
- Sanofi US Services Inc.$97K
- Boehringer Ingelheim International GmbH$65K
- AstraZeneca$65K
- plus $76K from 7 others
What the payments were for
- Travel & lodging$1,28782%
- Food & beverage$27518%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 11 | $1,561 |
How this compares
$1,561 in reported general payments places this provider in the 90th percentile of 2,469 hospitalist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 21 | $22,838 |
| MounjaroTirzepatide | 14 | $14,465 |
| Levothyroxine Sodium | 67 | $1,097 |
| Valsartan | 19 | $950 |
| SynthroidLevothyroxine Sodium | 14 | $811 |
| Metformin Er GastricMetformin Hcl | 12 | $787 |
| Losartan Potassium | 44 | $677 |
| Atorvastatin Calcium | 68 | $658 |
| Olmesartan Medoxomil | 19 | $627 |
| Rosuvastatin Calcium | 21 | $466 |
| Duloxetine Hcl | 11 | $372 |
| Montelukast Sodium | 11 | $328 |
| Amlodipine Besylate | 33 | $267 |
| Alendronate Sodium | 32 | $246 |
| Lisinopril | 29 | $174 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Long Beach
- Jennifer SchneiderSanta Rosa$1.2M
- Soham ShahBakersfield$844K
- Alpesh AminOrange$428K
- Retha GoodglickSanta Monica$156K
- Robert WachterSan Francisco$75K
- Steven WongTorrance$36K
- Edward LeeLos Angeles$30K
- Anjani KolahiOrange$30K
- Omar AldaasSan Diego$24K
- Summaiya MuhammadCastro Valley$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.